T-cell subsets in healthy teenagers: Transition to the adult phenotype
David J. Tollerud(National Cancer Institute), Robert N. Hoover(Tulane University), Línda Morris Brown(National Institutes of Health), Carolyn Y. Neuland(National Institutes of Health), Jeffrey W. Clark(Massachusetts General Hospital), Dean L. Mann, S T Ildstad(University of Louisville), William A. Blattner(Unknown), Luba K. Pankiw-Trost(National Institutes of Health)
Cited by 51
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k